We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Elan's fingers still crossed

30 October 2003 By Robert Cyran

The troubled Irish pharmaceuticals company hopes to raise around $450m to avoid massive dilution. The cash may solve liquidity problems, but it leaves Elan a massively geared bet on one drug. The troubled Irish pharmaceuticals company hopes to raise around $630m to avoid massive dilution.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)